Sensient Technologies Co. (SXT) Position Reduced by M&T Bank Corp

Share on StockTwits

M&T Bank Corp trimmed its position in shares of Sensient Technologies Co. (NYSE:SXT) by 3.5% during the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 8,691 shares of the specialty chemicals company’s stock after selling 317 shares during the quarter. M&T Bank Corp’s holdings in Sensient Technologies were worth $485,000 at the end of the most recent reporting period.

Other hedge funds have also recently made changes to their positions in the company. BlackRock Inc. lifted its stake in Sensient Technologies by 0.4% during the 3rd quarter. BlackRock Inc. now owns 4,832,355 shares of the specialty chemicals company’s stock valued at $369,727,000 after acquiring an additional 17,190 shares during the period. Vanguard Group Inc. lifted its stake in Sensient Technologies by 1.0% during the 3rd quarter. Vanguard Group Inc. now owns 4,273,291 shares of the specialty chemicals company’s stock valued at $326,949,000 after acquiring an additional 42,038 shares during the period. Vanguard Group Inc lifted its stake in Sensient Technologies by 1.0% during the 3rd quarter. Vanguard Group Inc now owns 4,273,291 shares of the specialty chemicals company’s stock valued at $326,949,000 after acquiring an additional 42,038 shares during the period. Janus Henderson Group PLC lifted its stake in Sensient Technologies by 6.0% during the 3rd quarter. Janus Henderson Group PLC now owns 4,045,926 shares of the specialty chemicals company’s stock valued at $309,554,000 after acquiring an additional 230,708 shares during the period. Finally, Atlanta Capital Management Co. L L C lifted its stake in Sensient Technologies by 270.6% during the 3rd quarter. Atlanta Capital Management Co. L L C now owns 1,132,357 shares of the specialty chemicals company’s stock valued at $86,637,000 after acquiring an additional 826,805 shares during the period. 99.73% of the stock is currently owned by institutional investors.

Shares of NYSE:SXT opened at $63.34 on Wednesday. Sensient Technologies Co. has a twelve month low of $51.93 and a twelve month high of $78.40. The company has a current ratio of 4.30, a quick ratio of 1.80 and a debt-to-equity ratio of 0.88. The company has a market capitalization of $2.66 billion, a PE ratio of 18.52 and a beta of 1.08.

Sensient Technologies (NYSE:SXT) last issued its quarterly earnings data on Friday, February 15th. The specialty chemicals company reported $0.79 earnings per share for the quarter, hitting the Thomson Reuters’ consensus estimate of $0.79. Sensient Technologies had a net margin of 9.92% and a return on equity of 18.43%. The firm had revenue of $324.56 million for the quarter. During the same quarter last year, the company earned $0.84 EPS. Sensient Technologies’s revenue for the quarter was down 1.3% on a year-over-year basis. As a group, analysts expect that Sensient Technologies Co. will post 3.55 EPS for the current fiscal year.

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, March 1st. Stockholders of record on Monday, February 4th will be paid a $0.36 dividend. This represents a $1.44 annualized dividend and a dividend yield of 2.27%. The ex-dividend date is Friday, February 1st. Sensient Technologies’s dividend payout ratio (DPR) is presently 42.11%.

Several equities analysts have issued reports on the stock. Zacks Investment Research cut shares of Sensient Technologies from a “hold” rating to a “strong sell” rating in a research note on Wednesday, October 24th. TheStreet cut shares of Sensient Technologies from a “b-” rating to a “c+” rating in a research note on Tuesday, December 18th. BNP Paribas initiated coverage on shares of Sensient Technologies in a research note on Friday, January 11th. They issued an “outperform” rating and a $74.00 price objective on the stock. KeyCorp set a $65.00 price objective on shares of Sensient Technologies and gave the stock a “buy” rating in a research note on Monday, January 14th. Finally, Exane BNP Paribas initiated coverage on shares of Sensient Technologies in a research note on Friday, January 11th. They issued an “outperform” rating and a $74.00 price objective on the stock. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and an average price target of $74.60.

ILLEGAL ACTIVITY NOTICE: “Sensient Technologies Co. (SXT) Position Reduced by M&T Bank Corp” was originally reported by Ticker Report and is the property of of Ticker Report. If you are reading this article on another website, it was copied illegally and republished in violation of U.S. and international copyright legislation. The original version of this article can be accessed at https://www.tickerreport.com/banking-finance/4165583/sensient-technologies-co-sxt-position-reduced-by-mt-bank-corp.html.

Sensient Technologies Company Profile

Sensient Technologies Corporation develops, manufactures, and supplies colors, flavors, and fragrances in the United States and internationally. It operates through three segments: Flavors & Fragrances Group, Color Group, and Asia Pacific Group. The company offers flavor-delivery systems, and compounded and blended products; ingredient products, such as essential oils, natural and synthetic flavors, natural extracts, and aroma chemicals; fragrance products; and chili powder, paprika, and chili pepper, as well as dehydrated vegetables comprising parsley, celery, and spinach to the food, beverage, personal care, and household-products industries.

Featured Story: What is insider trading?

Institutional Ownership by Quarter for Sensient Technologies (NYSE:SXT)

Receive News & Ratings for Sensient Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sensient Technologies and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

The Hong Kong and China Gas  vs. Sandridge Mississippian Trust I  Head to Head Survey
The Hong Kong and China Gas vs. Sandridge Mississippian Trust I Head to Head Survey
Contrasting Escalon Medical  & LivaNova
Contrasting Escalon Medical & LivaNova
$28.50 Million in Sales Expected for CRH Medical Corporation  This Quarter
$28.50 Million in Sales Expected for CRH Medical Corporation This Quarter
Speedy Hire  Receives “Buy” Rating from Liberum Capital
Speedy Hire Receives “Buy” Rating from Liberum Capital
Resources Connection, Inc.  Expected to Post Quarterly Sales of $184.03 Million
Resources Connection, Inc. Expected to Post Quarterly Sales of $184.03 Million
Kezar Life Sciences Inc  Receives Average Recommendation of “Buy” from Brokerages
Kezar Life Sciences Inc Receives Average Recommendation of “Buy” from Brokerages


© 2006-2019 Ticker Report